跳至主要内容
临床试验/NCT01359995
NCT01359995Unknown不适用

Topical Ganciclovir in Patients Receiving Penetrating Keratoplasty With Cytomegalovirus Endotheliitis

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2010年11月最近更新:
适应症

试验速览

阶段
不适用
入组人数
7
试验地点
1
主要终点
clinical courses before and after topical ganciclovir in patients with CMV endotheliitis

研究概览

简要总结

The purpose of this study was to evaluate the outcomes of topical ganciclovir in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty at National Taiwan University hospital.

详细描述

In this study, we recruit 7 immunocompetent patients with unexplained graft failures, which mimicked herpetic anterior uveitis and graft rejection initially, were diagnosed as CMV endotheliitis after aqueous tapping for CMV polymerase chain reaction (PCR). Topical ganciclovir was used to control and prevent the reactivation of CMV without systemic application and their clinical courses were presented after this treatment modality.

The purpose of this study was to evaluate the outcomes of topical ganciclovir in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty at National Taiwan University hospital.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • immunocompetent patients with positive results of the CMV PCR (polymerase chain reaction) from aqueous humor tapping receiving penetrating keratoplasty

排除标准

  • patients receiving systemic or intravitreal ganciclovir before topical ganciclovir use

结局指标

主要结局

clinical courses before and after topical ganciclovir in patients with CMV endotheliitis

时间窗: participants will be monitored after receiving topical ganciclovir,an expected average of 1 year

evaluations including aqueous PCR for CMV, endothelium cell density on confocal microscopy,degree of anterior chamber inflammation..

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验

Topical Ganciclovir in Patients Receiving... | 临床试验